169 related articles for article (PubMed ID: 29572189)
21. Activity-Based Probe for N-Acylethanolamine Acid Amidase.
Romeo E; Ponzano S; Armirotti A; Summa M; Bertozzi F; Garau G; Bandiera T; Piomelli D
ACS Chem Biol; 2015 Sep; 10(9):2057-2064. PubMed ID: 26102511
[TBL] [Abstract][Full Text] [Related]
22. Lysosome targeting fluorescent probe for NAAA imaging and its applications in the drug development for anti-inflammatory.
Zhou L; Tian M; Zhang B; Cao X; Huo X; Yang F; Cao P; Feng L; Ma X; Tian X
Int J Biol Macromol; 2024 Apr; 263(Pt 2):130307. PubMed ID: 38382784
[TBL] [Abstract][Full Text] [Related]
23. N-Acylethanolamine Acid Amidase contributes to disease progression in a mouse model of multiple sclerosis.
Pontis S; Palese F; Summa M; Realini N; Lanfranco M; De Mei C; Piomelli D
Pharmacol Res; 2020 Oct; 160():105064. PubMed ID: 32634582
[TBL] [Abstract][Full Text] [Related]
24. N-acylethanolamine hydrolyzing acid amidase inhibition: tools and potential therapeutic opportunities.
Bottemanne P; Muccioli GG; Alhouayek M
Drug Discov Today; 2018 Aug; 23(8):1520-1529. PubMed ID: 29567427
[TBL] [Abstract][Full Text] [Related]
25. N-Acylethanolamine-Hydrolyzing Acid Amidase Inhibition, but Not Fatty Acid Amide Hydrolase Inhibition, Prevents the Development of Experimental Autoimmune Encephalomyelitis in Mice.
Bottemanne P; Guillemot-Legris O; Paquot A; Masquelier J; Malamas M; Makriyannis A; Alhouayek M; Muccioli GG
Neurotherapeutics; 2021 Jul; 18(3):1815-1833. PubMed ID: 34235639
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and structure-activity relationship (SAR) of 2-methyl-4-oxo-3-oxetanylcarbamic acid esters, a class of potent N-acylethanolamine acid amidase (NAAA) inhibitors.
Ponzano S; Bertozzi F; Mengatto L; Dionisi M; Armirotti A; Romeo E; Berteotti A; Fiorelli C; Tarozzo G; Reggiani A; Duranti A; Tarzia G; Mor M; Cavalli A; Piomelli D; Bandiera T
J Med Chem; 2013 Sep; 56(17):6917-34. PubMed ID: 23991897
[TBL] [Abstract][Full Text] [Related]
27. N-Acylethanolamine acid amidase (NAAA) exacerbates psoriasis inflammation by enhancing dendritic cell (DCs) maturation.
Li Y; Li Y; Xu S; Chen Y; Zhou P; Hu T; Li H; Liu Y; Xu Y; Ren J; Qiu Y; Lu C
Pharmacol Res; 2022 Nov; 185():106491. PubMed ID: 36244543
[TBL] [Abstract][Full Text] [Related]
28. Diacerein is a potent and selective inhibitor of palmitoylethanolamide inactivation with analgesic activity in a rat model of acute inflammatory pain.
Petrosino S; Ahmad A; Marcolongo G; Esposito E; Allarà M; Verde R; Cuzzocrea S; Di Marzo V
Pharmacol Res; 2015 Jan; 91():9-14. PubMed ID: 25447594
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, biological evaluation, and structure activity relationship (SAR) study of pyrrolidine amide derivatives as
Zhou P; Xiang L; Zhao D; Ren J; Qiu Y; Li Y
Medchemcomm; 2019 Feb; 10(2):252-262. PubMed ID: 30931090
[No Abstract] [Full Text] [Related]
30. Discovery and SAR Evolution of Pyrazole Azabicyclo[3.2.1]octane Sulfonamides as a Novel Class of Non-Covalent
Di Fruscia P; Carbone A; Bottegoni G; Berti F; Giacomina F; Ponzano S; Pagliuca C; Fiasella A; Pizzirani D; Ortega JA; Nuzzi A; Tarozzo G; Mengatto L; Giampà R; Penna I; Russo D; Romeo E; Summa M; Bertorelli R; Armirotti A; Bertozzi SM; Reggiani A; Bandiera T; Bertozzi F
J Med Chem; 2021 Sep; 64(18):13327-13355. PubMed ID: 34469137
[TBL] [Abstract][Full Text] [Related]
31. Genetic Blockade of NAAA Cell-specifically Regulates Fatty Acid Ethanolamides (FAEs) Metabolism and Inflammatory Responses.
Xie X; Li Y; Xu S; Zhou P; Yang L; Xu Y; Qiu Y; Yang Y; Li Y
Front Pharmacol; 2021; 12():817603. PubMed ID: 35069223
[TBL] [Abstract][Full Text] [Related]
32. N-acylethanolamine acid amidase (NAAA) inhibition decreases the motivation for alcohol in Marchigian Sardinian alcohol-preferring rats.
Fotio Y; Ciccocioppo R; Piomelli D
Psychopharmacology (Berl); 2021 Jan; 238(1):249-258. PubMed ID: 33037452
[TBL] [Abstract][Full Text] [Related]
33. Second-Generation Non-Covalent NAAA Inhibitors are Protective in a Model of Multiple Sclerosis.
Migliore M; Pontis S; Fuentes de Arriba AL; Realini N; Torrente E; Armirotti A; Romeo E; Di Martino S; Russo D; Pizzirani D; Summa M; Lanfranco M; Ottonello G; Busquet P; Jung KM; Garcia-Guzman M; Heim R; Scarpelli R; Piomelli D
Angew Chem Int Ed Engl; 2016 Sep; 55(37):11193-11197. PubMed ID: 27404798
[TBL] [Abstract][Full Text] [Related]
34. Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages.
Sun YX; Tsuboi K; Zhao LY; Okamoto Y; Lambert DM; Ueda N
Biochim Biophys Acta; 2005 Oct; 1736(3):211-20. PubMed ID: 16154384
[TBL] [Abstract][Full Text] [Related]
35. The N-Acylethanolamine Acid Amidase Inhibitor ARN077 Suppresses Inflammation and Pruritus in a Mouse Model of Allergic Dermatitis.
Sasso O; Summa M; Armirotti A; Pontis S; De Mei C; Piomelli D
J Invest Dermatol; 2018 Mar; 138(3):562-569. PubMed ID: 29054595
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, structure-activity, and structure-stability relationships of 2-substituted-N-(4-oxo-3-oxetanyl) N-acylethanolamine acid amidase (NAAA) inhibitors.
Vitale R; Ottonello G; Petracca R; Bertozzi SM; Ponzano S; Armirotti A; Berteotti A; Dionisi M; Cavalli A; Piomelli D; Bandiera T; Bertozzi F
ChemMedChem; 2014 Feb; 9(2):323-36. PubMed ID: 24403170
[TBL] [Abstract][Full Text] [Related]
37. Predominant expression of lysosomal N-acylethanolamine-hydrolyzing acid amidase in macrophages revealed by immunochemical studies.
Tsuboi K; Zhao LY; Okamoto Y; Araki N; Ueno M; Sakamoto H; Ueda N
Biochim Biophys Acta; 2007 May; 1771(5):623-32. PubMed ID: 17462942
[TBL] [Abstract][Full Text] [Related]
38. Assay of NAAA Activity.
Tsuboi K; Ueda N
Methods Mol Biol; 2023; 2576():261-274. PubMed ID: 36152194
[TBL] [Abstract][Full Text] [Related]
39. N-Palmitoylethanolamine-oxazoline (PEA-OXA): A new therapeutic strategy to reduce neuroinflammation, oxidative stress associated to vascular dementia in an experimental model of repeated bilateral common carotid arteries occlusion.
Impellizzeri D; Siracusa R; Cordaro M; Crupi R; Peritore AF; Gugliandolo E; D'Amico R; Petrosino S; Evangelista M; Di Paola R; Cuzzocrea S
Neurobiol Dis; 2019 May; 125():77-91. PubMed ID: 30660740
[TBL] [Abstract][Full Text] [Related]
40. 2-pentadecyl-2-oxazoline: Identification in coffee, synthesis and activity in a rat model of carrageenan-induced hindpaw inflammation.
Impellizzeri D; Cordaro M; Bruschetta G; Crupi R; Pascali J; Alfonsi D; Marcolongo G; Cuzzocrea S
Pharmacol Res; 2016 Jun; 108():23-30. PubMed ID: 27083308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
